Funding Priority

Venture to Seek Scientific Solutions

Breakthroughs come from unexpected places. We must be empowered to take research down bold paths that lead to transformational treatments. With your help we will continue to reimagine the future of patient treatment and care, investing in pioneering research ventures that can alter the course and future of cancer research and treatment, and help uncover cures. We have identified and built up efforts in cellular immunotherapy, cancer genetics, academic drug discovery and big data. These are our “big bets”— research areas that can affect multiple disease types, and in which we also have a competitive advantage across the national landscape.

UNC Lineberger Comprehensive Cancer Center

    Science Nonfiction

    Changing the course for care means we must always stay ahead, pioneering scientific advancements and new treatments. This commitment to innovation has led UNC Lineberger to emerge as a national leader in numerous new areas that at one time would have been considered science-fiction.

    However, the reason we invest in such advancements isn’t simply to push the boundaries of discovery; it’s for the promise of better outcomes and improved lives after cancer. In January 2016, 60 year-old Ian Dale was diagnosed with an aggressive form of anaplastic large cell lymphoma. Despite undergoing traditional treatments, the chemotherapy and radiation couldn’t stop his cancer from relapsing. For Dale, the UNC Bone Marrow and Cellular Therapy Program offered a last ray of hope in the form of a clinical trial; one that genetically alters his immune cells (T-cells) to recognize and destroy cancer cells with limited side effects. Dale, who is now officially in remission, is living proof that cellular immunotherapy shows great promise.

    “I have a whole new lease on life. I’m here when I probably wouldn’t be,” says Dale. “I actually had a scan and was given the all clear. I’m officially a survivor.”

    UNC Lineberger is now one of only a few centers nationally to have the capabilities to develop and deliver this line of treatment. Trials are in the works for up to a half dozen types of cancer that could respond to this type of treatment. Immunotherapy represents the powerful future of cancer treatment, and we are helping to lead the way— and more important, clear the path to survival for patients.

    Empowering research through private giving.


    < Return to main pageOpens in new window

    More UNC Lineberger Funding Priorities

    Explore Stories

    Rich Preyer and Marilyn Jacobs Preyer

    Reducing Breast Cancer Disparities And Barriers To Care

    Rich Preyer and Marilyn Jacobs Preyer have donated $1 million to support UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study


    Grateful patient and husband establish breast cancer research fund

    Ensuring access to the most advanced care


    Deepening Our Understanding

    Using next generation sequencing to better understand COVID-19


    Precision Cancer Treatments

    "It's an exciting approach; we hit the tumor hard with little toxicity, leaving room for other therapy."

    Shelley Earp unc Lineberger

    Advancing Cancer Research and Care Across Carolina and the Globe

    As a nationally recognized cancer researcher and current director of UNC Lineberger Comprehensive Care Center, Shelton “Shelley” Earp is as comfortable in the lab as he is cheering for the Tar Heels in the Dean Dome.


    Breaking Down Precision Medicine

    UNC Lineberger designs, develops and delivers CAR-T therapy to to attack cancers.